TÜBİTAK 1507 — SME R&D Start-up, 2026 second call
The official 9 November extension notice sets the revised dates for the second 2026 SME R&D Start-up call. The programme supports SME R&D and innovation; the call documen…
TÜBİTAK · Turkey
Programme — suspended, check reopening
A historical suspension is documented. Current reopening is not verified; this is not an open-call listing.
Note: suspension notice; reopening not verified.
Programme profile retained for reference. TÜBİTAK’s 21 July 2026 notice announced a temporary application suspension from 7 August 2026 while the programme was updated. A subsequent reopening date has not been verified here.
Do not prepare or submit on the assumption that intake is open. Check current TÜBİTAK announcements and ARDEB PBS for updated programme terms.
Applicant categories are a starting point. The official call decides eligibility.
| Fact | Value | How we know | Taken from the source |
|---|---|---|---|
| Deadline | Unknown — not stated in the source we hold | unknown | — |
| Amount per applicant | Unknown — not stated in the source we hold | unknown | — |
| Total budget | Unknown — not stated in the source we hold | unknown | — |
| Funding rate | Unknown — not stated in the source we hold | unknown | — |
| Who can apply | Do not prepare or submit on the assumption that intake is open. Check current TÜBİTAK announcements and ARDEB PBS for updated programme terms. | read from the official text | 11 Nov 2026 |
| Where to apply | Unknown — not stated in the source we hold | unknown | — |
Facts on this page were read from the official page on 11 Nov 2026. The funder's own documents, including later amendments, always take precedence.
The official 9 November extension notice sets the revised dates for the second 2026 SME R&D Start-up call. The programme supports SME R&D and innovation; the call documen…
Order-based SME R&D support under the third 2026 call. TÜBİTAK’s extension notice gives the revised pre-registration and closing dates; applicants must consult the linked…
The 2027 joint call supports development and validation of innovative cell and gene therapies for personalised human medicine. Approaches include somatic-cell therapies, …
1831 - Yeşil İnovasyon Teknoloji Mentörlük Çağrısı. Call listed on TÜBİTAK's official open-calls page.
Supports scientifically based projects that generate knowledge, scientific interpretation or solutions to technological problems. Projects may last up to 36 months. This …